- Home
- FENC vs RFAI Comparison
FENC vs RFAI Comparison
Compare FENC & RFAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FENC
- RFAI
- Stock Information
- Founded
- FENC 1996
- RFAI 2024
- Country
- FENC United States
- RFAI Singapore
- Employees
- FENC N/A
- RFAI N/A
- Industry
- FENC Biotechnology: Biological Products (No Diagnostic Substances)
- RFAI
- Sector
- FENC Health Care
- RFAI
- Exchange
- FENC Nasdaq
- RFAI NYSE
- Market Cap
- FENC 156.9M
- RFAI 156.9M
- IPO Year
- FENC 2001
- RFAI 2024
- Fundamental
- Price
- FENC $5.95
- RFAI $10.48
- Analyst Decision
- FENC Strong Buy
- RFAI
- Analyst Count
- FENC 2
- RFAI 0
- Target Price
- FENC $14.00
- RFAI N/A
- AVG Volume (30 Days)
- FENC 50.4K
- RFAI 10.3K
- Earning Date
- FENC 05-20-2025
- RFAI 01-01-0001
- Dividend Yield
- FENC N/A
- RFAI N/A
- EPS Growth
- FENC N/A
- RFAI N/A
- EPS
- FENC N/A
- RFAI N/A
- Revenue
- FENC $47,538,000.00
- RFAI N/A
- Revenue This Year
- FENC $2.68
- RFAI N/A
- Revenue Next Year
- FENC $71.63
- RFAI N/A
- P/E Ratio
- FENC N/A
- RFAI $45.55
- Revenue Growth
- FENC 123.69
- RFAI N/A
- 52 Week Low
- FENC $3.96
- RFAI $10.00
- 52 Week High
- FENC $10.07
- RFAI $10.50
- Technical
- Relative Strength Index (RSI)
- FENC 51.33
- RFAI N/A
- Support Level
- FENC $5.85
- RFAI N/A
- Resistance Level
- FENC $6.61
- RFAI N/A
- Average True Range (ATR)
- FENC 0.36
- RFAI 0.00
- MACD
- FENC 0.06
- RFAI 0.00
- Stochastic Oscillator
- FENC 54.20
- RFAI 0.00
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
About RFAI RF ACQUISITION CORP II
RF Acquisition Corp II is a blank check company.